Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Prostate International|July 1, 2016
Feasibility of abiraterone acetate treatment in patients with metastatic castration-resistant prostate cancer and atrial fibrillationSimon Rauch, Dominic Fong, Elisa Morra, et al.
Future Oncology (London, England)|June 20, 2014
Potential value of rapid prostate-specific antigen decline in identifying primary resistance to abiraterone acetate and enzalutamideOrazio Caffo, Antonello Veccia, Francesca Maines, et al.
Molecular Cancer|June 14, 2013
EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growthAgnieszka Martowicz, Johannes Rainer, Julien Lelong, et al.
Cancers|July 27, 2022
Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCCLuca Marzi, Andrea Mega, Stefano Gitto, et al.
Cost Effectiveness and Resource Allocation : C/E|October 24, 2019
Cost-comparison analysis of a multiplatform tumour profiling service to guide advanced cancer treatmentGilbert Spizzo, Uwe Siebert, Guenther Gastl, et al.
Anticancer Research|August 5, 2003
Her2/neu expression in poorly-differentiated and anaplastic thyroid carcinomasChristian Ensinger, Rupert Prommegger, Dorotha Kendler, et al.
Anticancer Research|August 5, 2003
Her2/neu expression in C-cell hyperplasia and medullary thyroid carcinomasChristian Ensinger, Rupert Prommegger, Dorotha Kendler, et al.
Annals of Hematology|October 11, 2008
Hodgkin lymphoma in Tyrol-a population-based studyDominic Fong, Michael Steurer, Richard Greil, et al.
Mediastinum (Hong Kong, China)|July 16, 2025
Complete pathologic response after concomitant pembrolizumab and radiotherapy in a patient with pretreated metastatic thymic carcinoma: a case reportPaolo Mendogni, Riccardo Orlandi, Gilbert Spizzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patientsAlexander Perathoner, Daniela Pirkebner, Gerald Brandacher, et al.
Pageof 6